Vimarsana
Biggest News Aggregation in the World

Page 14 - Ohnson Johnson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ohnson Johnson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ohnson Johnson Today - Breaking & Trending Today

Sanitary Napkin Market to hit USD 41 billion by 2031, says Transparency Market Research Inc. - Vimarsana News

Sanitary Napkin Market to hit USD 41 billion by 2031, says Transparency Market Research Inc.

Subscription based models for the delivery of sanitary products have gained popularity. The services provide convenience and ensure a regular customer base.Wilmington, Delaware, United States, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc- The global sanitary napkin market was estimated to have acquired US$ 24.5 billion in 2021. It is anticipated to register a 5.0% CAGR from 2022 to 2031 and by 2031, the market is likely to gain US$ 41.0 billion. Innovations in absorption te

Source: yahoo.com
J&J faces 18 talc cancer trials, prompting it again to weigh bankruptcy - Vimarsana News

J&J faces 18 talc cancer trials, prompting it again to weigh bankruptcy

Since 2016, Johnson & Johnson has been hit with at least $570 million in damage awards over talc-related cancer claims and paid out at least $2.5 billion in settlements

First pill for dengue shows promise in human challenge trial - Vimarsana News

First pill for dengue shows promise in human challenge trial

A pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a small human challenge trial in the United States, according to data presented by the company on Friday. There are currently no specific treatments for dengue, a growing disease threat, the company said ahead of presentation of the data at the American Society of Tropical Medicine and Hygiene Annual Meeting in Chicago. “It is the first ever to show antiviral activity against dengue,” Marnix Van Loock, who oversees emerging pathogens research f...

Source: yahoo.com
J&J Weighs Third Bankruptcy to Resolve Tainted Baby Powder Suits - Vimarsana News

J&J Weighs Third Bankruptcy to Resolve Tainted Baby Powder Suits

(Bloomberg) -- Johnson & Johnson is weighing a third attempt to use bankruptcy for an $8.9 billion settlement of tens of thousands of lawsuits that allege tainted talc in the company’s baby powder caused cancer, the health-care giant told investors Tuesday.Most Read from BloombergHundreds Dead at Gaza Hospital as Israel, Hamas Trade BlameIsrael Latest: Biden ‘Deeply Saddened’ Over Hospital BlastTreasury Yields Climb as Hot Data Fuel Fed Wagers: Markets WrapWill Xi Jinping’s Gamble on Vladimir Pu

Source: yahoo.com
Johnson & Johnson (NYSE:JNJ) Q3 2023 Earnings Call Transcript - Vimarsana News

Johnson & Johnson (NYSE:JNJ) Q3 2023 Earnings Call Transcript

Johnson & Johnson (NYSE:JNJ) Q3 2023 Earnings Call Transcript October 17, 2023 Operator: Good morning, and welcome to Johnson & Johnson’s Third Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode until the question-and-answer session of the conference. This call is being recorded. If anyone has any objections, you may disconnect […]

Source: yahoo.com